Lyndsey O'Rourke
Physician Assistant · Lakewood, CONPI 1801367743
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $16,641 of the $18,931 with a category attached, or 87.9%. 31 manufacturers reported payments, led by AbbVie at 28.6% of the total. 2025 is the largest year on record at $6,765, 4.0 times the $1,696 reported in 2021. Among physician assistant clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 687 payments — averaging $27.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Johnson & Johnson$3K
- Gilead$2K
- Pfizer$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- plus $5K from 25 others
What the payments were for
- Consulting fees$2,14511%
- Food & beverage$16,64188%
- Education$1451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 231 | $5,405 |
| Johnson & Johnson | 55 | $2,930 |
| Gilead | 70 | $1,566 |
| Pfizer | 27 | $1,466 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $1,162 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 46 | $1,080 |
| Lilly USA, LLC | 17 | $703 |
| Regeneron Healthcare Solutions, Inc. | 33 | $665 |
| Bristol Myers Squibb | 28 | $557 |
| QOL Medical, LLC | 35 | $488 |
| Phathom Pharmaceuticals, Inc. | 17 | $459 |
| Madrigal Pharmaceuticals | 12 | $370 |
| Ardelyx, Inc. | 13 | $349 |
| Sanofi | 12 | $281 |
| Ipsen Biopharmaceuticals, Inc | 12 | $236 |
| Aimmune Therapeutics, Inc. | 5 | $208 |
| Janssen Scientific Affairs, LLC | 2 | $184 |
| Intercept Pharmaceuticals, Inc. | 5 | $138 |
| Intuitive Surgical | 1 | $100 |
| Celltrion USA Inc. | 4 | $98 |
| E.r. Squibb & Sons, L.L.C. | 1 | $95 |
| Nestle Healthcare Nutrition Inc. | 8 | $78 |
| Organon | 4 | $78 |
| Fresenius Kabi USA, LLC | 2 | $48 |
| Novo Nordisk | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Merck | 1 | $29 |
| Conmed Corporation | 1 | $23 |
| Vivus LLC | 1 | $19 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,931 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 31 | $161,194 |
| OcalivaObeticholic Acid | 12 | $116,537 |
| SimponiGolimumab | 12 | $97,710 |
| Humira(Cf) PenAdalimumab | 11 | $73,438 |
| CreonLipase/Protease/Amylase | 22 | $57,355 |
| LinzessLinaclotide | 47 | $27,554 |
| XifaxanRifaximin | 11 | $26,889 |
| Mesalamine | 59 | $24,620 |
| Budesonide DrBudesonide | 61 | $7,943 |
| Lubiprostone | 21 | $3,196 |
| Ursodiol | 26 | $2,965 |
| Esomeprazole Magnesium | 30 | $2,368 |
| Mesalamine ErMesalamine | 26 | $2,006 |
| Pantoprazole Sodium | 166 | $1,333 |
| Azathioprine | 38 | $1,197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Aimmune Therapeutics, Inc.Zenpep | $208 | $161,19431 claims |
| Intercept Pharmaceuticals, Inc.Ocaliva | $138 | $116,53712 claims |
| Johnson & JohnsonSimponi | $2,930 | $97,71012 claims |
| AbbVieCreon, Linzess | $5,405 | $84,90969 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $1,080 | $26,88911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Lakewood
- Rachel PrintyLakewood$35K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
- Emily FrischDenver$79K
- Daniel HumerLone Tree$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.